Publications by authors named "Shuka Furuki"

Claim this Profile
R
Risk factors for influenza virus infection in patients with hematological disease.
Hirotomo Nakashima, Shin-Ichiro Fujiwara, Seina Honda, Ryutaro Tominaga, Daizo Yokoyama, Shuka Furuki

Leuk Lymphoma· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significance of the tendency for relative bradycardia during induction therapy for acute myeloid leukemia.
Ryutaro Tominaga, Shin-Ichiro Fujiwara, Seina Honda, Daizo Yokoyama, Atsuto Noguchi, Shuka Furuki

Int J Hematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to initial treatment with glucocorticoids in TAFRO syndrome and implications for secondary treatment.
Ryutaro Tominaga, Kento Umino, Seina Honda, Daizo Yokoyama, Atsuto Noguchi, Shuka Furuki

Int J Hematol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Real-World Clinical Factors on an Analysis of the Cost-Effectiveness of "Immediate CAR-T" Versus "Late CAR-T" as Second-Line Treatment for DLBCL Patients.
Chihiro Yamamoto, Seina Honda, Ryutaro Tominaga, Daizo Yokoyama, Shuka Furuki

Transplant Cell Ther· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of daratumumab on the development of engraftment syndrome after autologous peripheral blood stem cell transplantation for multiple myeloma.
Daisuke Minakata, Shin-Ichiro Fujiwara, Seina Honda, Ryutaro Tominaga, Daizo Yokoyama, Shuka Furuki

Bone Marrow Transplant· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T-ALL presenting with i-TLP-like indolent clinical course with repeated spontaneous regressions.
Yumiko Toda, Ken Ohmine, Naoki Sano, Naoya Nakamura, Atsushi Kihara, Shuka Furuki

Pathol Res Pract· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of the pre-transplant CD4/CD8 ratio with the prognosis following allogeneic hematopoietic stem cell transplantation.
Takashi Nagayama, Shin-Ichiro Fujiwara, Ryutaro Tominaga, Daizo Yokoyama, Atsuto Noguchi, Shuka Furuki

Leuk Lymphoma· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of CD34 cell dose on engraftment and long-term outcomes after allogeneic bone marrow transplantation.
Takashi Oyama, Shin-Ichiro Fujiwara, Ryutaro Tominaga, Daizo Yokoyama, Atsuto Noguchi, Shuka Furuki

Clin Transplant· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness of Anti-BCMA Chimeric Antigen Receptor T Cell Therapy in Relapsed/Refractory Multiple Myeloma.
Chihiro Yamamoto, Daisuke Minakata, Daizo Yokoyama, Shuka Furuki, Atsuto Noguchi

Transplant Cell Ther· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early reversal of the lymphocyte-to-monocyte ratio after allogeneic-hematopoietic stem cell transplantation is associated with reduced relapse and improved prognosis.
Takashi Nagayama, Shin-Ichiro Fujiwara, Ryutaro Tominaga, Daizo Yokoyama, Atsuto Noguchi, Shuka Furuki

Clin Transplant· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis